Podcast Episodes
Back to SearchHighlights From ISC 2026: Insights Into Secondary Stroke Prevention From the OCEAN-STROKE Trial
Episode 628
Drs. Sanossian and Saver review new evidence supporting intensified antithrombotic strategies to reduce recurrent ischemic stroke in high-risk, nonca…
6 months, 1 week ago
CLL at ASH 2025: CLL17
Episode 627
Drs. O’Brien and Wierda discuss how fixed-duration venetoclax-based therapy can match continuous BTK inhibitor treatment in CLL while offering deep r…
6 months, 1 week ago
Neuromodulation in Migraine Care: Insights From the 2025 IHS Guidelines
Episode 626
Drs. Dougherty and Ailani discuss the 2025 International Headache Society guidelines indicating that neuromodulation is an effective, non-invasive op…
6 months, 1 week ago
Diagnosing Obstructive Hypertrophic Cardiomyopathy: Key Considerations for Clinicians
Episode 625
Drs. Maron and Rowin provide an overview of hypertrophic cardiomyopathy, explaining how it is diagnosed by heart imaging and classified into obstruct…
6 months, 1 week ago
ACR 2025: Risk of Proteinuria in Patients With Lupus Nephritis and the Timing of Kidney Biopsy in Patients With SLE
Episode 624
Drs. Petri and Woolfson discuss a simple risk score using autoantibodies, complement, and demographics to predict which SLE patients are most likely …
6 months, 1 week ago
Could anticoagulant choice cut bleeding risk in half for patients with acute VTE?
Episode 623
This week's podcast covers three NEJM trials. First, apixaban showed over 50% less clinically relevant bleeding than rivaroxaban in acute venous thro…
6 months, 1 week ago
2025 San Antonio Breast Cancer Symposium: Evolving First-Line Approaches in Metastatic HER2+ Breast Cancer
Episode 622
Drs. Isaacs and Traina discuss DESTINY-Breast09, where first‑line T‑DXd + pertuzumab clearly outperforms the CLEOPATRA regimen in progression-free su…
6 months, 2 weeks ago
Could personalized breast screening replace annual mammograms?
Episode 621
The WISDOM trial found risk-based breast cancer screening — using genetic and polygenic risk scores — is non-inferior to annual mammography, enabling…
6 months, 2 weeks ago
HER2+ Strategies in GI Cancers: ESMO 2025 Insights
Episode 620
Drs. Cytryn, Foote, and Thummalapalli review evolving HER2-targeted treatment strategies for upper GI, biliary, and colorectal cancers, emphasizing c…
6 months, 2 weeks ago
Could a new anti-CD20 therapy transform the treatment for systemic lupus?
Episode 619
Three studies highlight new findings: A phase 3 trial showed obinutuzumab significantly improved lupus responses versus placebo in active SLE patient…
6 months, 3 weeks ago